tiprankstipranks
Trending News
More News >
CytoMed Therapeutics Limited (GDTC)
NASDAQ:GDTC
US Market
Advertisement

CytoMed Therapeutics Limited (GDTC) Income Statement

Compare
15 Followers

CytoMed Therapeutics Limited Income Statement

Last quarter (Q2 2025), CytoMed Therapeutics Limited's total revenue was $105.70K, an increase of 27.87% from the same quarter last year. In Q2, CytoMed Therapeutics Limited's net income was $-882.30K. See CytoMed Therapeutics Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 52.01K$ 290.56K$ 0.00$ 84.18K$ 44.92K
Gross Profit
$ 52.38K$ 381.92K$ -81.03K$ 81.59K$ 41.43K
Operating Expenses
$ 1.87M$ 1.58M$ 1.62M$ 937.15K$ 891.67K
Depreciation and Amortization
$ 91.59K$ 77.47K$ 293.32K$ 243.92K$ 220.99K
EBITDA
$ -1.79M$ -2.94M$ -1.10M$ -1.05M$ -776.21K
Operating Income
$ -2.63M$ -3.20M$ -1.70M$ -1.40M$ -1.00M
Other Income/Expenses
$ 739.13K$ 122.21K$ -572.86K$ -128.34K$ -400.12K
Pretax Income
$ -1.89M$ -3.08M$ -2.27M$ -1.53M$ -1.40M
Net Income
$ -1.88M$ -3.13M$ -2.27M$ -1.53M$ -1.47M
Per Share Metrics
Basic EPS
$ -0.16$ -0.29$ -0.30$ -0.22$ -0.25
Diluted EPS
$ -0.16$ -0.29$ -0.30$ -0.22$ -0.25
Weighted Average Shares Outstanding
11.54M 10.63M 7.92M 6.93M 5.90M
Weighted Average Shares Outstanding (Diluted)
11.54M 10.63M 7.92M 6.93M 5.90M
Currency in USD

CytoMed Therapeutics Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis